Skip to main content

Published locations for Better efficacy-safety with 3-week vs 4-week nab-paclitaxel in HER2− metastatic BC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Better efficacy-safety with 3-week vs 4-week nab-paclitaxel in HER2− metastatic BC

User login

  • Reset your password
  • /content/better-efficacy-safety-3-week-vs-4-week-nab-paclitaxel-her2-metastatic-bc
  • /breast-cancer-icymi/article/266536/breast-cancer/better-efficacy-safety-3-week-vs-4-week-nab